Cost-Effectiveness of Rivaroxaban Within Subgroups for Atrial Fibrillation and Venous Thromboembolism in The Netherlands
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1758
https://www.valueinhealthjournal.com/article/S1098-3015(16)33124-2/fulltext
Title :
Cost-Effectiveness of Rivaroxaban Within Subgroups for Atrial Fibrillation and Venous Thromboembolism in The Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33124-2&doi=10.1016/j.jval.2016.09.1758
First page :
A652
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1660